| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/03/1996 | CN1119546A An alcohol-based disinfectant preparation and the use thereof |
| 04/03/1996 | CN1119531A A stably storable and readily water soluble composition of cephalosporin for injections |
| 04/03/1996 | CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 04/03/1996 | CN1119529A Method of promoting hair growth |
| 04/03/1996 | CN1119528A A contraceptive for use by a male |
| 04/02/1996 | US5504228 From acylation of hydrolysates of silk waste; mainly-glycine, alanine and serine |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504215 Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation |
| 04/02/1996 | US5504213 Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives |
| 04/02/1996 | US5504212 Inhibitors of farnesyl-protein transferase |
| 04/02/1996 | US5504210 Treatment for cardiovascular disorders |
| 04/02/1996 | US5504209 2-amino-5-cyano-4-quinolydihydropyridine esters, processes for their preparation and their use in medicaments |
| 04/02/1996 | US5504207 Reacting 4-amino-2-chloro-6,7-dimethoxyquinazoline with n-(2-tetrahydrofuroyl)piperazine in anhydrous polar solvent without acid scavenger |
| 04/02/1996 | US5504205 Reduced sp3 texaphyrins |
| 04/02/1996 | US5504204 Immunosuppressive, antiinflammatory, antifungal, antiproliferative and antitumor agents |
| 04/02/1996 | US5504203 Reacting tri-keto derivative with an alkyl cyanacetate, epoxidation, reduction, hofmann degradation, optional releasing of 3-ketone |
| 04/02/1996 | US5504117 Topically administering a nitric oxide donor |
| 04/02/1996 | US5504116 Lidocaine for the management of preterm labor |
| 04/02/1996 | US5504115 Inhibitors of farnesyl protein transferase |
| 04/02/1996 | US5504114 Administering conjugated linoleic acid to female birds to prevent eggs from hatching |
| 04/02/1996 | US5504113 Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
| 04/02/1996 | US5504111 Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome |
| 04/02/1996 | US5504108 Optically pure 4-aryl-2-hydroxytetronic acids |
| 04/02/1996 | US5504107 Anticoagulants, preventing atherosclerosis |
| 04/02/1996 | US5504105 In oily vehicles that promote absorption enabling dosage to be simplified |
| 04/02/1996 | US5504103 Contacting cells with antitumor agents |
| 04/02/1996 | US5504102 Solution of teniposide, paclitaxel, or camptothecin and derivatives antitumor agent and polyethoxylated castor oil mixed with acid to lower the carboxylate anion content; shelf-life, by-product inhibition |
| 04/02/1996 | US5504099 Storage stable aqueous diuretic solution containing azosemide salt of organic amine and biocompatible organic solvent |
| 04/02/1996 | US5504094 Use of bengothiophenls to treat pain due to an excess of neuropeptide y |
| 04/02/1996 | US5504093 Administering a carbostyril derivative |
| 04/02/1996 | US5504092 Use of Linomide to increase hemopoietic cell precursors |
| 04/02/1996 | US5504090 Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
| 04/02/1996 | US5504089 Treating urinary incontinence |
| 04/02/1996 | US5504088 Acetylcholine esterase inhibitors; alzheimer's disease and other diseases caused by a low concentration of choline |
| 04/02/1996 | US5504086 Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone |
| 04/02/1996 | US5504085 Treating ischemia, anoxia, hypoglycemia and head, spinal cord trauma |
| 04/02/1996 | US5504084 Pharmaceutical for the treatment of skin disorders |
| 04/02/1996 | US5504081 Administering nicotinergic acetylcholine receptor antagonists and agonists |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5504079 Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4 |
| 04/02/1996 | US5504074 Administering substituted estranes to suppress vascularization |
| 04/02/1996 | US5504073 Administering a methyl-(2-(hexadecyloxy)-phenyl) methyl ester phosphonic acid to treat atherosclerosis; phospholipase a2 inhibition |
| 04/02/1996 | US5503997 A process for producing legionella specific antibiotic using Streptomyces sp. AL91 |
| 04/02/1996 | US5503973 Method for inhibition of viral morphogenesis |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 04/02/1996 | US5503845 Produced by intensive moistening of active ingredient with more than 30 weight per cent water in a granulator with maximum energy input |
| 04/02/1996 | US5503843 Transdermal delivery of alpha adrenoceptor blocking agents |
| 04/02/1996 | CA1338230C Sulfated polysaccharide |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/30/1996 | CA2159425A1 New heterocycle substituted imidazolidines; process and intermediates for preparing them and their use as drugs; pharmaceutical compositions containing the same |
| 03/30/1996 | CA2133284A1 Octacarboxy substituted tetra(2,3-pyrazino)porphyrazines and their derivatives |
| 03/28/1996 | WO1996009406A1 A method for identifying and using compounds that inactivate hiv-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| 03/28/1996 | WO1996009405A1 Treatment of plasmodium |
| 03/28/1996 | WO1996009392A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) [Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) [APO(a)] |
| 03/28/1996 | WO1996009387A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009316A1 Parallel selex |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009310A1 Derivatives of carbohydrates and compositions containing them |
| 03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
| 03/28/1996 | WO1996009302A1 Bicyclic carboxamides as 5-ht1a antagonists |
| 03/28/1996 | WO1996009300A1 Novel intermediate for production and process for producing pyridine derivative |
| 03/28/1996 | WO1996009299A1 Drugs to improved synaptic transmission |
| 03/28/1996 | WO1996009297A1 Compositions and methods for treating mast-cell inflammatory condition |
| 03/28/1996 | WO1996009295A1 Quinoxaline derivatives useful in therapy |
| 03/28/1996 | WO1996009294A1 Substituted heteroaromatic compounds and their use in medicine |
| 03/28/1996 | WO1996009288A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 03/28/1996 | WO1996009287A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 03/28/1996 | WO1996009286A1 Isothiourea derivatives as no synthase inhibitors |
| 03/28/1996 | WO1996009284A1 Novel carbamate compounds and processes for preparing the same |
| 03/28/1996 | WO1996009283A1 Novel carbamate compounds and processes for preparing the same |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009073A1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 03/28/1996 | WO1996009072A1 Estramustine formulations with improved pharmaceutical properties |
| 03/28/1996 | WO1996009069A1 Novel medicinal use of 5ht3 antagonist |
| 03/28/1996 | WO1996009068A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 03/28/1996 | WO1996009063A1 Use of muramyl peptide compounds |
| 03/28/1996 | WO1996009058A1 Remedy and preventive for nervous system disorder |
| 03/28/1996 | WO1996009057A1 Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men |
| 03/28/1996 | WO1996009056A1 Process of making dosage units by wet granulation |
| 03/28/1996 | WO1996009055A1 New use of prostaglandins |
| 03/28/1996 | WO1996009054A1 Method and means for prevention and treatment of secondary cataract |
| 03/28/1996 | WO1996009053A1 Oxidoreductase activity of manganic porphyrins |
| 03/28/1996 | WO1996009052A1 A method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds |
| 03/28/1996 | WO1996009051A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | WO1996009050A1 Methods of inhibiting endometrial mitoses |
| 03/28/1996 | WO1996009049A1 Inhibition of plasmodia parasites by camptothecin compounds |
| 03/28/1996 | WO1996009048A1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
| 03/28/1996 | WO1996009047A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| 03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
| 03/28/1996 | WO1996009045A1 Antiestrogenic benzothiophenyl compounds |
| 03/28/1996 | WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 03/28/1996 | WO1996009043A1 Methods for the treatment of inflammatory joint disease |
| 03/28/1996 | WO1996009042A1 Compositions and methods for the control of smoking |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 03/28/1996 | WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |